Ning An
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Inflammasome and immune disorders 5
- Fibroblast Growth Factor Research 4
- Nephrology 15
- Chronic Kidney Disease and Diabetes 5
- Co-authors
- Chen Yang (17 shared papers)Qingjun Pan (12 shared papers)Jialu Liu (11 shared papers)H. Wu (8 shared papers)Xiaocui Chen (9 shared papers)Zhihang Li (7 shared papers)Jing Xue (3 shared papers)Zhihong Wu (3 shared papers)
- Journals
- AIDS Research and Human Retroviruses (5 papers)Frontiers in Immunology (3 papers)Biomedicine & Pharmacotherapy (2 papers)Acta Pharmacologica Sinica (2 papers)Frontiers in Physiology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ning An
63 papers receiving 836 citations
Peers
Comparison fields: 5 of 89
- Nephrology 120
- Immunology 161
- Rheumatology 97
- Pathology and Forensic Medicine 77
- Complementary and alternative medicine 35
Countries citing papers authored by Ning An
This map shows the geographic impact of Ning An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning An more than expected).
Fields of papers citing papers by Ning An
This network shows the impact of papers produced by Ning An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning An. The network helps show where Ning An may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 81 | |
| 2 | 2018 | 62 | |
| 3 | 2017 | 59 | |
| 4 | 2017 | 54 | |
| 5 | 2018 | 47 | |
| 6 | 2022 | 35 | |
| 7 | 2022 | 29 | |
| 8 | 2017 | 25 | |
| 9 | 2011 | 25 | |
| 10 | 2024 | 25 | |
| 11 | 2022 | 23 | |
| 12 | 2020 | 23 | |
| 13 | 2018 | 23 | |
| 14 | 2017 | 22 | |
| 15 | 2021 | 22 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 18 | |
| 18 | 2022 | 17 | |
| 19 | 2014 | 16 | |
| 20 | 2022 | 15 |
About Ning An
Ning An is a scholar working on Molecular Biology, Nephrology, Immunology, Infectious Diseases and Virology, having authored 69 papers that have together received 844 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (7 papers), Autophagy in Disease and Therapy (6 papers), Chronic Kidney Disease and Diabetes (5 papers), Inflammasome and immune disorders (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Nephrology (120 citations), Immunology (161 citations), Rheumatology (97 citations), Pathology and Forensic Medicine (77 citations) and Complementary and alternative medicine (35 citations). Ning An has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chen Yang, Qingjun Pan, Jialu Liu, H. Wu, Xiaocui Chen, Zhihang Li, Jing Xue, Zhihong Wu, Huafeng Liu and Yanwen Chen. Their work appears in journals such as AIDS Research and Human Retroviruses, Frontiers in Immunology, Biomedicine & Pharmacotherapy, Acta Pharmacologica Sinica and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.